Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Linical Co Ltd
2183Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan. Address: Shin-Osaka Brick Building, Osaka, Japan, 532-0003
Analytics
Zielpreis von Wall Street
421 193.25 JPYKGV
24.4295Dividendenrendite
4.2 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen 2183
Dividenden-Analyse 2183
Dividendenwachstum über 5 Jahre
27 %Kontinuierliches Wachstum
1 JahrAusschüttungsquote 5-Jahres-Durchschnitt
36 %Verlauf der Dividende 2183
Bewertung der Aktie 2183
Finanzen 2183
Ergebnisse | 2019 | Dynamik |